The arrival of the 17th volume of LUPUS is as good a time to reflect as any.
All of us who work for the journal have been delighted by its success. For a 'one disease' journal, not affiliated to any particular college or society, to have reached a steady impact factor (currently 2.4) is something of a success story. But, impact factors are not the only yardstick of success and indeed they have their detractors. Equally rewarding, but less easy to measure, are the many colleagues who have written to us describing LUPUS as an iconic read -a stimulating mix of clinical and laboratory reports, with occasional series including 'Lupus around the world' and 'Eminence-based Medicine' (of course our critics may have kept their powder dry).
Throughout our seventeen year life, we have also published a number of leaders and reviews in which the authors have not been afraid to predict -at the risk of subsequently being proved wrong -trends or clinical associations, which they have considered significant.
I would like to encourage more of these speculative pieces in future -if only to stimulate clinical collaborative research or to focus minds. Some examples of observations, which deserve such an approach are given here: Why don't lupus patients catch cold? Many, many patients comment on this observation -that during cold and flu epidemics they seem to be the only family member not affected.
Is malignancy less common in lupus? I believe sothe association of nonHodgkins lymphoma with other
